BLAKE MEDLEY: Open Payments
NPI 1043880834 · TALBOTT, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$890 in 55 payments from 14 companies in 2025. Trend: 2023 $1,007 · 2024 $1,543 · 2025 $890
Food & beverage: $890
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $279 |
| Novo Nordisk Inc | 11 | $141 |
| Axsome Therapeutics, Inc. | 5 | $108 |
| PFIZER INC. | 4 | $66 |
| Sage Therapeutics, LLC | 3 | $60 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $54 |
| Merck Sharp & Dohme LLC | 2 | $38 |
| Corcept Therapeutics | 2 | $32 |
| Supernus Pharmaceuticals, Inc. | 1 | $21 |
| Lundbeck LLC | 1 | $21 |
Products named: QULIPTA, UBRELVY, Symbravo, ZURZUVAE, Wegovy, CAPLYTA, NURTEC ODT, VRAYLAR.
Industry payments across TN — which companies pay providers there.
